全文获取类型
收费全文 | 5788篇 |
免费 | 443篇 |
国内免费 | 315篇 |
专业分类
6546篇 |
出版年
2024年 | 22篇 |
2023年 | 179篇 |
2022年 | 231篇 |
2021年 | 287篇 |
2020年 | 269篇 |
2019年 | 353篇 |
2018年 | 303篇 |
2017年 | 225篇 |
2016年 | 267篇 |
2015年 | 281篇 |
2014年 | 364篇 |
2013年 | 588篇 |
2012年 | 222篇 |
2011年 | 247篇 |
2010年 | 183篇 |
2009年 | 211篇 |
2008年 | 229篇 |
2007年 | 237篇 |
2006年 | 226篇 |
2005年 | 180篇 |
2004年 | 172篇 |
2003年 | 139篇 |
2002年 | 147篇 |
2001年 | 97篇 |
2000年 | 57篇 |
1999年 | 70篇 |
1998年 | 79篇 |
1997年 | 59篇 |
1996年 | 52篇 |
1995年 | 51篇 |
1994年 | 45篇 |
1993年 | 39篇 |
1992年 | 31篇 |
1991年 | 31篇 |
1990年 | 20篇 |
1989年 | 25篇 |
1986年 | 16篇 |
1985年 | 23篇 |
1984年 | 40篇 |
1983年 | 23篇 |
1982年 | 19篇 |
1981年 | 27篇 |
1980年 | 28篇 |
1979年 | 26篇 |
1978年 | 21篇 |
1977年 | 14篇 |
1976年 | 15篇 |
1975年 | 15篇 |
1974年 | 18篇 |
1973年 | 16篇 |
排序方式: 共有6546条查询结果,搜索用时 15 毫秒
21.
22.
23.
N E Owen 《Biochemical and biophysical research communications》1984,125(2):500-508
The regulation of Na/K/Cl cotransport was investigated in vascular smooth muscle cells. That a Na/K/Cl cotransport system exists was established by the finding that the ouabain insensitive K influx was sensitive to the "loop" diuretic bumetanide. Furthermore, bumetanide sensitive K influx was dependent upon the presence of both Na and Cl in the extracellular milieu. Bumetanide sensitive K influx was inhibited by agents which elevate cellular cyclic AMP levels, and to a lesser extent by agents which elevate cellular cyclic GMP levels. When serum, EGF or TPA was added, bumetanide sensitive K influx was enhanced. These results suggest that vascular smooth muscle cells have a ouabain insensitive, bumetanide sensitive Na/K/Cl cotransport system which is stimulated by serum, EGF or TPA and inhibited by cAMP or cGMP. 相似文献
24.
Yajun Zheng Colin M. Tice Suresh B. Singh 《Bioorganic & medicinal chemistry letters》2017,27(13):2825-2837
In structure-based drug design, the basic goal is to design molecules that fit complementarily to a given binding pocket. Since such computationally modeled molecules may not adopt the intended bound conformation outside the binding pocket, one challenge is to ensure that the designed ligands adopt similar low energy conformations both inside and outside of the binding pocket. Computational chemistry methods and conformational preferences of small molecules from PDB and Cambridge Structural Database (CSD) can be used to predict the bound structures of the designed molecules. Herein, we review applications of conformational control in structure-based drug design using selected examples from the recent medicinal chemistry literature. The main purpose is to highlight some intriguing conformational features that can be applied to other drug discovery programs. 相似文献
25.
26.
The small chaperone protein Hsp27 confers resistance to apoptosis, and therefore is an attractive anticancer drug target. We report here a novel mechanism underlying the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sensitizing activity of the small molecule , an inactive analog of the phosphoinositide 3-kinase inhibitor inhibitor LY303511, in HeLa cells that are refractory to TRAIL-induced apoptosis. On the basis of the fact that LY294002 is derived from LY303511, itself derived from quercetin, and earlier findings indicating that quercetin and LY294002 affected Hsp27 expression, we investigated whether LY294002 sensitized cancer cells to TRAIL via a conserved inhibitory effect on Hsp27. We provide evidence that upon treatment with LY303511, Hsp27 is progressively sequestered in the nucleus, thus reducing its protective effect in the cytosol during the apoptotic process. LY303511-induced nuclear translocation of Hsp27 is linked to its sustained phosphorylation via activation of p38 kinase and MAPKAP kinase 2 and the inhibition of PP2A. Furthermore, Hsp27 phosphorylation leads to the subsequent dissociation of its large oligomers and a decrease in its chaperone activity, thereby further compromising the death inhibitory activity of Hsp27. Furthermore, genetic manipulation of Hsp27 expression significantly affected the TRAIL sensitizing activity of LY303511, which corroborated the Hsp27 targeting activity of LY303511. Taken together, these data indicate a novel mechanism of small molecule sensitization to TRAIL through targeting of Hsp27 functions, rather than its overall expression, leading to decreased cellular protection, which could have therapeutic implications for overcoming chemotherapy resistance in tumor cells. LY303511相似文献
27.
28.
29.
Four nonconjugative broad-host-range cloning vectors were derived from the W-plasmid Sa. They are small (Mr 5.6?7.2 × 106), carry several drug-resistance markers, and allow constructing and screening for recombinant plasmids generated by the restriction enzymes EcoRI, PstI, BglII, HindIII, BamHI and SalI, 相似文献
30.
肝癌先天性多表达多药耐药基因,严重影响肝癌的化疗效果,筛选肝癌细胞中的耐药基因,研究其耐药机制有助于提高肝癌化疗效果,提高肝癌的治愈率。首先构建肝癌细胞逆转录病毒的cDNA文库,感染成纤维细胞,使得逆转录病毒基因整合进细胞,加药筛选,存活细胞中的基因再次包装成病毒,用于下一轮筛选。采用循环包装回收(Cyclical packaging rescue,CPR)技术进行肝癌细胞耐药基因的筛选即是通过病毒包装将基因从细胞中钓取出来,相比于常规筛选方法,仅通过一轮筛选可能会出现很多假阳性基因,采用CPR技术则是通过多轮筛选,很大程度减少了假阳性细胞的出现。通过该方法经过四轮筛选获得核糖体蛋白S11(RPS11)、核糖体蛋白L6(RPL6)、核糖体蛋白L11(RPL11)、核糖体蛋白L24(RPL24)等几种基因,经初步检测,增加了细胞的耐药性。 相似文献